EW (Edwards Lifesciences) OCF Yield %: 2.61 (As of Jun. 25, 2026) — Near Median


EW Edwards Lifesciences Corp EW
97 GF Score
Price $90.34
GF Value $93.17
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Edwards Lifesciences OCF Yield %?

Edwards Lifesciences EW +0.75% 97 OCF Yield % is 2.61 as of Jun. 25, 2026, which is 8% above its 10-year median of 2.42. GuruFocus rates EW with a GF Score™ of 97/100 and a GF Value™ of $93.17 (Fairly Valued). The stock has 5 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Edwards Lifesciences ranks better than 53.99% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Edwards Lifesciences's Trailing 12-Month Cash Flow from Operations is $1,359 Mil, and Market Cap is $52,015 Mil. Therefore, Edwards Lifesciences's OCF Yield % for today is 2.61%.

The historical rank and industry rank for Edwards Lifesciences's OCF Yield % or its related term are showing as below:

EW' s OCF Yield % Range Over the Past 10 Years
Min: 0.94   Med: 2.42   Max: 4.01
Current: 2.61


During the past 13 years, the highest OCF Yield % of Edwards Lifesciences was 4.01%. The lowest was 0.94%. And the median was 2.42%.

EW's OCF Yield % is ranked better than
53.99% of 852 companies
in the Medical Devices & Instruments industry
Industry Median: 1.76 vs EW: 2.61

Edwards Lifesciences's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Edwards Lifesciences OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Edwards Lifesciences OCF Yield % Related Terms


Edwards Lifesciences OCF Yield % Historical Data

* Premium members only.

The historical data trend for Edwards Lifesciences's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edwards Lifesciences OCF Yield % Chart

Edwards Lifesciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.14 2.68 1.95 1.24 3.22

Edwards Lifesciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.64 2.52 5.08 3.64 0.38

EW vs DXCM, GEHC, BSX: OCF Yield % Comparison

For the Medical Devices subindustry, Edwards Lifesciences's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edwards Lifesciences OCF Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's OCF Yield % falls into.


EW
97GF Score
Edwards Lifesciences Corp EW
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Edwards Lifesciences OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Edwards Lifesciences's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=1595.2 / 49504.675
=3.22%

Edwards Lifesciences's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=43.8 * 4 / 46206.16
=0.38%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 2.61 mean?
Edwards Lifesciences (EW) has a OCF Yield % of 2.61 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Edwards Lifesciences and its competitors. This is near median its historical median of 2.42. Over the past decade, Edwards Lifesciences' OCF Yield % has ranged from 0.94 to 4.01. According to the industry distribution chart, Edwards Lifesciences ranks #392 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 46%.
Is Edwards Lifesciences' OCF Yield % too high?
Edwards Lifesciences' current OCF Yield % of 2.61 is near median its 10-year median of 2.42. Over the past 10 years, this metric has ranged from a low of 0.94 to a high of 4.01. The Medical Devices & Instruments industry median OCF Yield % is 1.76. Edwards Lifesciences' value of 2.61 is 48.3% above this industry median. Based on the distribution chart, Edwards Lifesciences ranks #392 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Edwards Lifesciences has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Edwards Lifesciences' OCF Yield % compare to DXCM and GEHC?
According to the Medical Devices & Instruments industry distribution chart, Edwards Lifesciences ranks #392 out of 852 companies for OCF Yield %. This puts Edwards Lifesciences in the upper half of its industry. The industry median OCF Yield % is 1.76. Edwards Lifesciences' value of 2.61 is 48.3% above this benchmark. Historically, Edwards Lifesciences' own OCF Yield % has ranged from 0.94 to 4.01 over the past decade. While the company's 10-year median is 2.42 vs. the industry median of 1.76, Edwards Lifesciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.76, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Edwards Lifesciences's current OCF Yield % of 2.61 is 48.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Edwards Lifesciences and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Edwards Lifesciences's current OCF Yield % is 2.61, which is near median its own 10-year median of 2.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edwards Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Edwards Lifesciences (EW) is currently considered Fairly Valued. The stock's GF Value™ is $93.17, compared to a current price of $90.34 — trading 3% below its estimated fair value. The current OCF Yield % is 2.61, which is near median its 10-year median of 2.42 and 48.3% above the Medical Devices & Instruments industry median of 1.76. Edwards Lifesciences' overall GF Score™ is 97/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Edwards Lifesciences (EW), the current OCF Yield % is 2.61 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Edwards Lifesciences (EW) Overvalued in 2026?

Based on GuruFocus' analysis, Edwards Lifesciences stock appears to be undervalued. The current stock price of $90.34 is trading 3% below its estimated GF Value™ of $93.17. GuruFocus considers Edwards Lifesciences to be Fairly Valued.

Key valuation signals for EW:

  • OCF Yield %: 2.61 (near median its 10-year median of 2.42)
  • GF Value™: $93.17 vs. price of $90.34 (3% below fair value)
  • GF Score™: 97/100 with 5 warning signs
  • Industry Position: 48.3% above the Medical Devices & Instruments median (#392 of 852)

No single metric tells the full story. See the EW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Edwards Lifesciences Business Description

Address One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
97GF Score

Get the complete analysis for EW

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$90.34
Price
$93.17
GF Value